Our Mission
To eliminate breast cancer care inequalities by transforming the speed, cost and accuracy of recurrence risk prediction
Our Story
As medical research scientists, ‘hope’ as a strategy for cancer care was not an option. Our goal was to transform the hope that clinicians and their patients would have access to an accurate, timely, and affordable predictive test into a reality.
We understand that for patients, the risk of cancer recurrence is one of their greatest fears. For clinicians, the risk of recurrence is a key indicator to guide post-operative care, provide a personalised medicinal approach, and forms a critical part of the treatment decision-making pathway that guides whether chemotherapy is required or not.
So, we started a digital revolution in cancer risk and understanding.
Powered by a team of leading physicists and oncologists, we uniquely combined infrared multi-spectral imaging (spectrometry) with Artificial Intelligence (AI) to deliver a breakthrough in patient care.
We developed a way of eliminating the subjectivity inherent in traditional biomarker analysis… In a radically faster way … At a dramatically lower cost.
Thereby creating an opportunity to accelerate informed treatment decision-making and advance cancer patient outcomes.
What the experts say
